Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. In 2025, Gilead announced a $32 billion investment to further strengthen its U.S. footprint to power the next era of discovery, job creation and public health preparedness - while continuing to invest globally to ensure patients everywhere benefit from its scientific innovation. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif.
B OF A GLBL RES · BAIRD R W · BARCLAYS CAPITA · BMO CAPITAL MKT · CANTOR FITZGERA · CO FORECST · DBS BANK · DEUTSCHE BK SEC · EDWARD JONES · HSBC GLOBAL RES · JEFFERIES & CO. · JP MORGAN SECUR · LEERINK PARTNRS · MAXIM GROUP,LLC · MIZUHO SECURITI · MORGAN STANLEY · OPPENHEIMER HLD · PIPER SANDLER · RAYMOND JAMES · RBC CAPITAL · TD COWEN · TRUIST SECURITI · WELLS FARGO SEC · ZACKS RESEARCH
日线来自 Yahoo Finance，2026-04-20 至 2026-10-19。区间涨跌按首尾收盘价算，不含分红与拆股调整之外的任何处理。 图表可以滚轮缩放、拖动平移，移到哪根看哪根。